GlassScriptPhysician profile
Sonal Pruthi
NPI 1902289606
$8,726.03
in general payments reported to CMS, 2019-2025
24 companies · $3,534 in 2025
The $3,534 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.74 · 2022: $147 · 2023: $3,457 · 2024: $1,573 · 2025: $3,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,897 · Travel and Lodging: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,897.49 |
| Travel and Lodging | $2,666.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,618.62 | 2023-2025 | Indigo System |
| Boston Scientific Corporation | $2,085.52 | 2022-2025 | Avvigo Guidance System, Opticross, Rotapro |
| Abbott Laboratories | $659.87 | 2023 | Supera, Coroflow, Xact |
| Boehringer Ingelheim Pharmaceuticals, INC. | $513.24 | 2022-2025 | Jardiance |
| Stryker Corporation | $486.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Shockwave Medical, INC | $391.97 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $390.77 | 2024-2025 | Impella |
| Medtronic, INC. | $243.41 | 2023 | Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $202.19 | 2024-2025 | |
| Inari Medical, INC. | $194.49 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.95 | 2024-2025 | Lifevest |
| Cardiva Medical, INC. | $126.12 | 2022-2023 | Cardiva Vascade 5f Vcs |
| Cagent Vascular INC | $118.38 | 2024-2025 | Serrantor |
| Astrazeneca Pharmaceuticals LP | $115.93 | 2021-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $93.84 | 2023-2024 | Xarelto |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $81.09 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $42.72 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $42.62 | 2025 | Nexletol |
| Imperative Care, INC | $35.00 | 2025 | Symphony Catheter |
| Alnylam Pharmaceuticals INC. | $29.50 | 2025 | Amvuttra |
| Asahi Intecc USA, INC. | $28.31 | 2023 | Asahi Ptca Guide Wire |
| Edwards Lifesciences Corporation | $25.94 | 2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $23.96 | 2024 | (Ck7) Extended Holter |
| Terumo Medical Corporation | $18.24 | 2023 | Glidewire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Pruthi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.